Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Antidepressant use and colorectal cancer risk
Pharmacoepidemiology and Drug Safety, 09/11/09
Coogan PF et al. – The authors found an association of reduced risk of colorectal cancer with regular use of SSRIs. In light of laboratory data indicating that SSRIs may inhibit colon cancer and one previous epidemiologic study that also observed a decreased risk, further investigation of the effect of SSRIs on the risk of colorectal cancer is warranted.
Related Articles
The Role of Sodium Channels in the Mechanism of Action of Antidepressants and Mood Stabilizers
Current Drug Targets, 10/30/09
Relevance Score: 87%
Increase In Long-term Antidepressant Drug Use, UK Study Reveals
ScienceDaily, 10/26/09
Relevance Score: 87%
Study reveals an increase in long-term antidepressant drug use
EurekAlert, 10/23/09
Relevance Score: 87%
Review: differences in efficacy and acceptability exist for 12 new-generation antidepressants for major depression
Evidence-Based Medicine, 10/26/09
Relevance Score: 84%
Diabetes incidence associated with depression and antidepressants in the Melbourne Longitudinal Studies on Healthy Ageing (MELSHA)
International Journal of Geriatric Psychiatry, 10/09/09
Relevance Score: 84%
Today in Colorectal Cancer/Polyps...keeping you current
Receive free subspecialty "5-minute updates" via email
EORTC Elderly Task Force experts opinion for the treatment of colon cancer in older patients
Cancer Treatment Reviews, 12/04/09
Bevacizumab combined with chemotherapy for patients with advanced colorectal cancer: a systematic review
Annals of Oncology, 12/04/09
A phase I study of axitinib (AG-013736) in combination with bevacizumab plus chemotherapy or chemotherapy alone in patients with metastatic colorectal cancer and other solid tumors
Annals of Oncology, 12/04/09
Sponsor
Article Search
Sponsor


See Latest Articles


